Resources
Practice resources
Product Information, patient education materials, and other resources.
Patient Information
Patient information on Multiple Myeloma, Products, and patient resources like financial support and and copay cards.
OncExpert
onExpert Multiple Myeloma provides access to the latest information on Standard of Care, Clinical Trials, Targeted Agents, and Emerging Science
Myeloma News
Powered By:
- Study Finds Racial Disparities In Treatment Of Multiple Myeloma Patients
- CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
- Nektar Therapeutics Announces Initiation of First-in-Human Phase 1 Clinical Study of NKTR-255, an IL-15 Agonist, in Adults with Relapsed or Refractory Non-Hodgkin Lymphoma or Multiple Myeloma
- Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple Myeloma
- Xospata Leads Latest CHMP Recommendations
- Study in JNCCN Supports Idea that Higher Patient Volumes are Associated with Longer Survival in Multiple Myeloma